Total Payments
$12,767
2024 Payments
$3,423
Companies
40
Transactions
444
Medicare Patients
49
Medicare Billing
$4,880
Payment Breakdown by Category
Food & Beverage$12,307 (96.4%)
Education$440.83 (3.5%)
Consulting$18.80 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,307 | 437 | 96.4% |
| Education | $440.83 | 6 | 3.5% |
| Consulting Fee | $18.80 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,667 | 50 | $0 (2024) |
| Novo Nordisk Inc | $1,170 | 31 | $0 (2024) |
| ABBVIE INC. | $1,021 | 40 | $0 (2024) |
| Lilly USA, LLC | $982.77 | 43 | $0 (2024) |
| GlaxoSmithKline, LLC. | $916.70 | 44 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $728.40 | 16 | $0 (2024) |
| PFIZER INC. | $725.86 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $665.26 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $595.29 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $542.97 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,423 | 140 | AstraZeneca Pharmaceuticals LP ($434.59) |
| 2023 | $3,568 | 128 | Lilly USA, LLC ($426.33) |
| 2022 | $3,214 | 104 | AstraZeneca Pharmaceuticals LP ($455.38) |
| 2021 | $2,562 | 72 | AstraZeneca Pharmaceuticals LP ($656.10) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: RESPIRATORY | ||||||
| 12/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Obesity | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: PAIN | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $123.51 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.36 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: Cardio-renal | ||||||
| 11/25/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $121.72 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: Cardio-renal | ||||||
| 11/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $93.95 | General |
| 11/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $67.95 | General |
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: Biological | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 36 | 120 | $14,280 | $4,378 |
| 2020 | 1 | 13 | 13 | $1,872 | $501.53 |
Total Patients
49
Total Services
133
Medicare Billing
$4,880
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 12 | 54 | $6,912 | $2,242 | 32.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 12 | 54 | $6,912 | $1,992 | 28.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2022 | 12 | 12 | $456.00 | $144.32 | 31.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 13 | $1,872 | $501.53 | 26.8% |
About Gina Cuneo-Ramos
Gina Cuneo-Ramos is a Family healthcare provider based in Newburgh, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1477970663.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gina Cuneo-Ramos has received a total of $12,767 in payments from pharmaceutical and medical device companies, with $3,423 received in 2024. These payments were reported across 444 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($12,307).
As a Medicare-enrolled provider, Cuneo-Ramos has provided services to 49 Medicare beneficiaries, totaling 133 services with total Medicare billing of $4,880. Data is available for 2 years (2020–2022), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Newburgh, NY
- Active Since 03/25/2014
- Last Updated 01/20/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477970663
Products in Payments
- FARXIGA (Drug) $771.63
- TRELEGY ELLIPTA (Drug) $732.74
- Kerendia (Drug) $728.40
- MOUNJARO (Drug) $708.41
- NURTEC ODT (Drug) $625.71
- BREZTRI (Drug) $561.17
- UBRELVY (Drug) $460.54
- Wegovy (Drug) $456.90
- REXULTI (Drug) $437.59
- CAPLYTA (Drug) $379.95
- DUPIXENT (Biological) $372.63
- VRAYLAR (Drug) $344.29
- TRADJENTA (Drug) $338.70
- JARDIANCE (Drug) $277.04
- ELIQUIS (Drug) $273.87
- ARISTADA (Drug) $259.74
- Ozempic (Drug) $244.07
- LYBALVI (Drug) $192.74
- Auvelity (Drug) $189.06
- Rybelsus (Drug) $181.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Newburgh
Krista Land, Np-C, NP-C
Family — Payments: $4,140
Family $4,140
Amy Wall, Fnp, FNP
Family — Payments: $3,938
Family $3,938
Lynn Schnautz, Np, NP
Family — Payments: $3,842
Family $3,842
Adrianna Hyams, Np-C, NP-C
Family — Payments: $3,837
Family $3,837
Laura Nicholson, Fnp, FNP
Family — Payments: $3,263
Family $3,263
Kristin Joiner, Np, NP
Family — Payments: $2,967
Family $2,967